BTT1023 in Psoriasis

NCT00871598 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: BTT1023
DRUG: Placebo
DRUG: BTT1023

Sponsor

Biotie Therapies Corp.